Background: Although reactive oxygen species (ROS) have been produced in both mouse bone marrow-derived dendritic cells (DCs) and XS-106 DCs by contact sensitizers and irritants in previous studies, the generation of ROS in human monocyte-derived DCs (MoDCs) and their role in contact hypersensitivity (CHS) has yet to be elucidated. Objective: The purpose of this study was to determine whether contact allergens and irritants induce ROS in MoDCs and, if so, to evaluate the role of contact allergen and irritant induced-ROS in MoDCs in CHS. Methods: Production of ROS was measured by 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) assay. Surface CD86 and HLA-DR molecules were detected by flow cytometry. Protein carbonylation was detected by Western blotting. Results: ROS were produced by contact allergens such as dinitrochlorobenzene (DNCB) and thimerosal and the irritant benzalkonium chloride (BKC). DNCB-induced, but not BKC-induced, ROS increased surface CD86 and HLA-DR molecules on MoDCs and induced protein carbonylation. These changes were reduced in the presence of antioxidant N-acetyl cysteine. Conclusion: Our results suggest that DNCB-induced ROS may be different from those induced by irritant BKC. The DNCB-induced ROS may be associated with the CHS response, because they activate surface molecules on DCs that are important for generating immune reactions. 
INTRODUCTION
Reactive oxygen species (ROS) are important players in host defenses against bacterial infection 1, 2 , skin aging 3,4 , cancer 5 , and various chronic diseases 6 . However, little is known about the role of ROS in skin diseases 7 and contact hypersensitivity (CHS). ROS are molecular oxygen derivatives that have various functions in cells 8 . Besides acting as direct bacterial killing mechanisms, ROS also stimulate the immune response through activation of signaling pathways, upregulation of surface co-stimulatory molecules, protein carbonylation, and secretion of proinflammatory cytokines such as IL-12 9 . ROS induction and inactivation are tightly regulated by enzymatic and non-enzymatic antioxidant systems 10 . Interruption of this system can lead to increased amounts of ROS, especially secondary or toxic ROS that are potentially damaging to cellular macromolecules 5, 6 .
Contact dermatitis is an inflammatory skin disorder caused by environmental skin-sensitizing substances and is classified into 2 types: allergic contact dermatitis (ACD) and irritant contact dermatitis (ICD). ACD is considered to be a cell-mediated, delayed-type hypersensitivity immune response 11 , whereas ICD is thought to be a non-immunological, local inflammatory reaction to chemicals. As mentioned above, ROS can be important in CHS; for this reason, the ROS-inducing potential of various contact allergens and irritants in DCs has been studied. Antigen presenting cells play an essential role in the T cell-mediated immune response 12, 13 . In the skin, there are different antigen presenting cells localized in the epidermis (Langerhans cells [LCs] ) and dermis (dermal dendritic cells [DDCs] ). However, after applying haptens to the epidermis of mice genetically engineered to be deficient in LCs, decreased CHS response was not observed 14 . Therefore, whether or not LCs are involved in the induction of CHS remains controversial. Recently DDCs were reported to be more important than LCs in CHS 14 . Monocyte-derived DCs (MoDCs) have similar characteristics to DDCs or interstitial DCs 15 . Therefore,
MoDCs were used as the experimental model in the present study. The purpose of this study was to determine whether ROS are induced by contact allergens and irritants in MoDCs and, if so, to evaluate the role of hapten or irritant induced-ROS in CHS. 
MATERIALS AND METHODS

Reagents and stimulation of DCs
Generation of MoDCs
MoDCs were generated as previously described 16, 17 .
Briefly, mononuclear cells were separated by a density gradient using Ficoll-Paque PLUS (GE Healthcare BioSciences AB, Uppsala, Sweden) and monocyte cells were isolated by the plastic adherence method, incubating the mononuclear cells in 3% X-VIVO for 40 min and washing vigorously with PBS to remove non-adherent lymphocytes. Isolated monocytes were cultured in 10% plasma in X-VIVO 15 for 6 days with 800 U/ml of rhGM-CSF and 1,000 U/ml of rhIL-4. On alternate days, 1 ml of culture medium was removed and fresh medium containing rhGM-CSF and rhIL-4 was added.
ROS detection using CM-H 2 DCFDA by flow cytometric analysis
After treatment with sublethal concentrations of chemicals, MoDCs were harvested, washed twice with prewarmed PBS, and resuspended in 50μl PBS. 
The expression of surface molecules on MoDCs
To determine the phenotypes of DCs, the following surface molecules were analyzed by flow cytometry. Mouse monoclonal fluorescence-conjugated antibodies (mAbs) against CD86 (FITC), HLA-DR (FITC), CD80 (PE), and CD83 (PE) (BD Pharmingen, San Diego, CA, USA) and the appropriate isotype controls were used. After treatment with haptens or irritants for 24 and 48 h, MoDCs were harvested, washed, and stained with the above mAbs. Samples were analyzed by flow cytometry.
Cytokine production from MoDCs
Culture supernatants of MoDCs were analyzed by enzyme-linked immunosorbent assay (ELISA), according to the manufacturer's provided protocols. IL-1β, TNFα, and IL-12p70 cytokines were purchased from R&D Systems Inc. (Minneapolis, MN, USA) and ELISA was performed according to the manufacturer's protocol.
Protein extraction and Western blotting
The cytoplasmic and nuclear proteins were extracted using ProteoJET Cytoplasmic and Nuclear Protein Extraction Kit (Fermentas Inc, Baltimore, MD, USA) according to the manufacturer's protocol. The protein concentrations were determined using BCA assay. 30μg of proteins were loaded by 10% SDS-PAGE and electrotransferred to poly- 
Statistical analysis
Production of ROS and expression of surface molecules were described through mean fluorescence intensity using flow cytometry. Data were analyzed using a Student's t-test. For statistical analyses, we used SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). p-values ＜0.05 were considered to be significant.
RESULTS
Allergens (DNCB, TNBS, Thim, and DNFB) and irritants (BKC and SDS) produce ROS by MoDCs
After determining the optimal concentrations of chemicals to use (Table 1) , immature MoDCs were exposed to contact allergens and irritants to examine ROS induction. Of the contact sensitizers studied, DNCB, TNBS, Thim, and DNFB were found to induce ROS. DNCB, TNBS, Thim and DNFB increased ROS production 3.8-fold, 2.9-fold, 3.3-fold, and 1.5-fold, respectively, compared to the control. Of these, the relative increase of ROS production by DNCB, Thim, and DNFB were statistically significant (p-values were 0.031, 0.029, and 0.034, respectively). ROS production after treatment with HQ, cobalt, and nickel was not detectable (data not shown). Of the irritants used, BKC and SDS induced ROS significantly (the relative ROS increase with BKC was 2.6-fold and that with SDS was 2.0-fold; p-values were 0.028 and 0.013, respectively) ( Fig. 1) .
ROS induced by allergens cause protein carbonylation, but irritant-induced ROS do not
MoDCs were treated with DNCB and BKC and carbonylated proteins were detected using anti-DNP antibody by Western blotting. Although the allergen DNCB and the irritant BKC both induced ROS similarly, only DNCB exposure was associated with protein carbonylation ( Fig. 2 ).
Contact sensitizer DNCB up-regulates the expression of CD86 and HLA-DR on MoDCs but irritant BKC does not
To demonstrate that immature MoDCs treated with DNCB and BKC have enhanced expression of CD80, CD86, CD83, and HLA-DR, we used flow cytometry analysis. CD86 and HLA-DR expression on MoDCs cultured with DNCB were increased 2.5-fold and 1.2-fold, respectively (with p-values of 0.018 and 0.033, respectively), compared to that of the control, which was statistically significant (Fig. 3A, C and Table 2A ), while CD80 and CD83 expression was not augmented by DNCB. In contrast, irritant BKC did not induce the expression of all surface molecules on MoDCs (Fig. 3B, D) .
The effects of antioxidants on ROS production, expression of surface molecules, and protein carbonylation
1) ROS production induced by DNCB and BKC was diminished in the presence of NAC
After demonstrating the production of ROS from MoDCs cultured with DNCB and BKC, the effect of the antioxidant NAC on these ROS production was examined (Fig. 4A) . Pre-treatment of MoDCs with 5 mM of NAC reduced the ROS production induced by DNCB significantly (the relative ROS increase with DNCB treatment was 3.8-fold while that with pre-treatment with NAC plus DNCB treatment was 0.56-fold p≤0.0001). BKC-induced ROS production was decreased by pre-treatment with NAC (the relative ROS increase of BKC was 2.6-fold while that with pre-treatment with NAC plus BKC treatment was 0.70-fold).
2) Protein carbonylation induced by DNCB-derived ROS was decreased slightly by NAC
To confirm that protein carbonylation is induced by ROS, we used antioxidant NAC, expecting that protein car- bonylation would decrease as the amount of ROS decreased. After incubation of MoDCs treated with DNCB in the presence of 5 mM NAC, the carbonylated protein level was indeed found to be decreased (Fig. 4B ).
3) Upregulation of CD86 and HLA-DR on MoDCs by DNCB-induced ROS was decreased by NAC
To verify that DNCB-induced up-regulation of CD86 and HLA-DR is related to the generation of ROS, we examined these parameters with the addition of the antioxidant NAC. MoDCs were treated with DNCB in the presence or absence of NAC and cell surface molecules were analyzed by flow cytometry. Augmentation of CD86 and HLA-DR by DNCB was decreased by adding 10 mM NAC ( Fig. 4C and Table 2B ). Pre-treatment of MoDCs with 5 mM of NAC reduced the ROS production induced by DNCB significantly (the relative ROS increase with DNCB treatment was 3.8-fold while that with pre-treatment with NAC plus DNCB treatment was 0.56-fold. p≤0.0001). BKC-induced ROS production was decreased by pre-treatment with NAC (the relative ROS increase with BKC treatment was 2.6-fold while that with pre-treatment with NAC plus BKC treatment was 0.70-fold). Each experiment was repeated three times and one representative result is shown. (B) These carbonylated proteins were decreased slightly by NAC. Immature day 6 MoDCs were incubated with 20μM DNCB or 10μM BKC in the presence or absence of 5 mM NAC for 30 min. After 6 h, equal amounts of whole cell protein extracts were loaded in SDS gel and carbonylated proteins were detected using DNP antibody by Western blotting. Allergen DNCB but not irritant BKC induced protein carbonylation and the resulting carbonylated protein was decreased slightly by NAC. 
ROS: reactive oxygen species, BKC: benzalkonium chloride, DNCB: dinitrochlorobenzene, NAC: N-acetyl cysteine, DPI: diphenylene iodonium, NMMA: N-monomethyl-L-arginine, ＋: reduction of ROS, −: no effect on ROS level. 
Allergen and irritant-induced ROS generated from different sources
Allergen-and irritant-induced ROS may have a distinct role depending on their source. The source of ROS generated by each substance was examined and we found that contact allergen DNCB induced-ROS are reduced in the presence of diphenylene iodonium (DPI) (Fig. 5A) while the irritant BKC induced-ROS are decreased slightly by N-monomethyl-L-arginine (NMMA) (Fig. 5B and Table 3 ).
Cytokine production of MoDCs treated with DNCB and BKC
Cytokine secretion (IL-1β, IL-12p70, and TNFα) was assayed with ELISA in MoDCs treated by the contact allergen DNCB or the irritant BKC. TNF-α secretion in the DNCB-and BKC-treated MoDCs were increased by 1.8-fold and 2.7-fold respectively compared to the control, but these increments were not statistically significant. Other cytokines (IL-1β, IL-12p70) were not detectable in the DNCB-and BKC-treated MoDCs (Table 4) .
DISCUSSION
Using the well-established mouse XS-106 DC line and mouse bone marrow-derived DCs, we previously demonstrated that contact allergens induce ROS, which in turn stimulate IL-12 cytokine secretion and the Th1 response during CHS 9, 18 . We therefore sought to confirm the result in the human system. In the first part of this experiment, the optimal concentration of haptens and irritants, at which the percentage of live cells exceeded 90%, was found after incubation with these substances for 1 h and 24 h (Table 1) . Subsequently, ROS levels were measured to determine whether these chemicals did in fact induce ROS in MoDCs, which was confirmed. The ASI, N,N 1 -DCCD, was used as a positive control and catalase was used as an enzymatic inhibitor of ROS. The results were similar to those of our previous study 18 29 . Pretreatment with GSH alone did not affect the ROS level; however, its precursor NAC did reduce the ROS level. This may be due to the fact that high concentrations of reduced GSH in the cell interfere with the diffusion of GSH into cells. GSH is abundant in the cytoplasm (1∼11 mM), in the mitochondria (3∼11 mM), and in the nucleus (5∼15 mM) 30 .
Surface molecule expression varied depending on the chemicals that were applied to cells. Expression of CD86, ICAM (CD54) and HLA-DR molecules on MoDCs was upregulated by contact allergens 31 while the amount of CD80 and CD83 molecules was not increased. Our study demonstrated that these upregulations were dependent on the ROS. Rutault et al. 20 reported that hydrogen peroxide induces upregulation of several DC surface molecules, such as MHC class II and co-stimulatory molecules including CD40 and CD86, and that this enhancement is blocked by NAC. These results confirm the results of our previous studies 9, 18 which showed that ROS produced by contact allergen increase surface molecules and produce cytokines such as IL-12p70 in mouse XS-106 DCs cell lines 9 and mouse bone-marrow derived DCs 18 . This study also proves that the results obtained from the mouse system are similar to that of the human system. Irritant BKC did not cause an increase in any of the co-stimulatory molecules on MoDCs. Even though both DNCB and BKC produced ROS from MoDCs, the ROS produced by DNCB and BKC have different roles in the change of surface molecules of MoDCs. Therefore, it may be useful to further characterize the types of ROS produced by DNCB and BKC in future studies. Furthermore, it may be necessary to use other detection methods besides the CM-H2DCFDA assay. Among the cytokines (IL-1β, IL-12p70, and TNFα) involved in CHS, only TNF-α secretion was detected after treatment with DNCB and BKC in this study. Other groups have also reported the detection of TNF-α at mRNA level 32 and small amounts of TNF-α at the protein level after treatment with DNCB 33 . Cytokines (IL-1β, IL-12p70)
at the protein level in MoDCs were undetected both in the control and experimental groups in this study. Contact allergen and irritant alone may not be sufficient stimulus leading to the secretion of the biologically active form of IL-1β, but when combined with other molecules such as LPS or TNF-α, they can further enhance the production of IL-1β 34 . IL-12p70 was easily secreted by mouse XS-106
DCs after incubation with contact allergen 9 in our previous study. We could not detect, however, any trace of IL-12p70 in the control and experimental groups in this experiment. This may be explained through the fact that MoDCs, different from the mouse XS106 DCs line, do not typically secrete IL-12p70. The mere fact that ROS, in the process of antigen presentation, play a role in the activation of DCs and their interactions with T cells 35 , together with the fact that extracellular superoxide dismutase impairs LC migration and therefore suppresses mouse CHS 36 , confirms the involvement of ROS in CHS. Our study has further demonstrated the involvement of ROS in CHS through hapten-induced ROS production in human MoDCs, similar to that of the involvement of ROS in mouse CHS, which was shown through hapten-induced ROS production in mouse XS 106 DC line 9 and mouse bone marrow DCs 18 .
In conclusion, our results suggest that DNCB and BKC may induce different ROS in MoDCs. DNCB-induced ROS may induce the CHS response by activating DC.
